Potential Roles of the Glass Transition Temperature of PLGA Microparticles in Drug Release Kinetics.

Poly(lactic--glycolic acid) (PLGA) has been used for long-acting injectable drug delivery systems for more than 30 years. The factors affecting the properties of PLGA formulations are still not clearly understood. The drug release kinetics of PLGA microparticles are influenced by many parameters associated with the formulation composition, manufacturing process, and post-treatments. Since the drug release kinetics have not been explainable using the measurable properties, formulating PLGA microparticles with desired drug release kinetics has been extremely difficult. Of the various properties, the glass transition temperature, , of PLGA formulations is able to explain various aspects of drug release kinetics. This allows examination of parameters that affect the of PLGA formulations, and thus, affecting the drug release kinetics. The impacts of the terminal sterilization on the and drug release kinetics were also examined. The analysis of drug release kinetics in relation to the of PLGA formulations provides a basis for further understanding of the factors controlling drug release.